# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-100723
Filing Date
2025-04-28
Accepted
2025-04-28 16:46:29
Documents
22
Period of Report
2025-06-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | d904380dpre14a.htm iXBRL | PRE 14A | 761281
6 | GRAPHIC | g904380dsp013.jpg | GRAPHIC | 173399
7 | GRAPHIC | g904380dsp014.jpg | GRAPHIC | 125742
8 | GRAPHIC | g904380g23b81.jpg | GRAPHIC | 63081
9 | GRAPHIC | g904380g37o81.jpg | GRAPHIC | 60671
10 | GRAPHIC | g904380g41z56.jpg | GRAPHIC | 169376
11 | GRAPHIC | g904380g81d74.jpg | GRAPHIC | 152379
| Complete submission text file | 0001193125-25-100723.txt |  | 3353176

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | nams-20241231.xsd | EX-101.SCH | 3314
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nams-20241231_def.xml | EX-101.DEF | 2263
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nams-20241231_lab.xml | EX-101.LAB | 2257
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nams-20241231_pre.xml | EX-101.PRE | 1300
24 | EXTRACTED XBRL INSTANCE DOCUMENT | d904380dpre14a_htm.xml | XML | 183250

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41562 | Film No.: 25881202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)